Business Context and Reporting Period
This Form 8-K Current Report was filed by Virtuix Holdings Inc. on July 21, 2026. The registrant is incorporated in Delaware and its common stock (Trading Symbol: VTIX) is listed on the Nasdaq Global Market. The report discloses the entry into material definitive agreements regarding warrant amendments.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the terms of warrant amendments rather than operational financial performance.
Material Changes and Agreements
On July 21, 2026, the Company entered into amendments with Streeterville Capital, LLC regarding three specific warrants to purchase Class A Common Stock:
- Equity Financing Warrant (originally dated August 25, 2025).
- Second Debt Financing Warrant (originally dated October 30, 2025).
- Third Debt Financing Warrant (originally dated December 19, 2025).
Key Terms of the Amendments:
- Exercise Price Reduction: The exercise price was reduced from $3.00 to $2.50 per share.
- Reduced Exercise Price Period: This lower price is effective from July 21, 2026, through August 27, 2026.
- Expiration Extension: The expiration date of the warrants and the Reduced Exercise Price Period is extended to August 27, 2026.
- Automatic Extension: The period automatically extends for four additional consecutive one-month periods unless the Special Committee of the Board of Directors determines not to extend.
- Termination Right: The Company may terminate the Reduced Exercise Price Period at any time with two trading days' prior written notice, causing the exercise price to revert to the Nasdaq Valuation Price.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond the terms of the warrant agreements. The primary contingency noted is the Company's right to terminate the reduced exercise price period, which would increase the cost for the investor to exercise the warrants.
Investor Verification Checklist
- Verify the total number of shares underlying the three amended warrants to assess potential dilution.
- Confirm the current Nasdaq Valuation Price to understand the price reversion risk if the Company terminates the reduced period.
- Review the full text of Exhibits 4.1, 4.2, and 4.3 for any additional covenants or conditions not summarized in the 8-K.
- Monitor future filings to determine if the Special Committee elects to extend the Reduced Exercise Price Period beyond the initial August 27, 2026 date.